Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin

By Gordon Michael A   Zhang Wu   Yang Dongyun   Iqbal Syma   El-Khouiery Anthony   Nagashima Fumio   Lurje Georg   Labonte Melissa   Wilson Peter   Sherrod Andy   Ladner Robert D   Lenz Heinz-Josef  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 27-39

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of 5-Fluorouracil/Oxaliplatin in Colorectal Cancer

By  

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 277-283

Bentham Science Publishers

Access to resources Recommend Favorite

Beyond 5-fluorouracil: new horizons in systemic therapy for advanced colorectal cancer

By Khamly Kenneth   Jefford Michael   Michael Michael   Zalcberg John  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 607-628

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer

By Cattel L.   La Grotta G.   Infante L.   Passera R.   Arpicco S.   Brusa P.   Bumma C.  

Il Farmaco, Vol. 58, Iss. 12, 2003-12 ,pp. : 1333-1338

Elsevier

Access to resources Recommend Favorite

Intratumoural Thymidylate Synthase and Dihydropyrimidine Dehydrogenase Activities Are Good Predictors of 5-Fluorouracil Sensitivity in Colorectal Cancer

By Ishibiki Y   Kitajima M   Sakamoto K   Tomiki Y   Sakamoto S   Kamano T  

The Journal of International Medical Research, Vol. 31, Iss. 3, 2003-05 ,pp. : 181-187

Field House Publishing

Access to resources Recommend Favorite